Shroom Maps
← Back to Directory

For Clinicians

Oregon runs the first regulated psilocybin program in the United States. If you have clients asking about it, this page covers what the program is, what it is not, and where you fit.

Two things to know up front. The program is not a medical system — no prescription, no diagnosis, no referral. And as of January 1, 2026, if you hold a license from one of seven Oregon boards, you can now do this work yourself without risking that license.

How the Program Works

Oregon voters passed the Psilocybin Services Act in 2020. It is codified at ORS 475A and administered by Oregon Psilocybin Services (OPS), a section of the Oregon Health Authority’s Public Health Division.

Every client engagement has three phases. All of it happens through a licensed facilitator. Administration happens only at a licensed service center.

Preparation Session

Required before any client consumes psilocybin. The facilitator conducts intake, reviews informed consent and the Client Bill of Rights, discusses accessibility needs, and builds a safety and support plan and a transportation plan with the client.

The client completes a standardized Client Information Form. The facilitator decides whether they can provide services. The client decides whether to proceed. Either party can stop here.

Administration Session

Takes place at a licensed service center. This is the only point at which a client may purchase or consume psilocybin products. Nothing leaves the premises.

The client stays at the center for a minimum duration set by the dose consumed. Group sessions require minimum client-facilitator ratios.

Integration Session

The facilitator must attempt to reach the client within 72 hours of the administration session to check in, record any post-session reactions, and offer an optional integration session. Integration is the client’s choice. It covers the safety and support plan, the experience itself, and referrals out.

Who Is Eligible

Clients must be 21 or older. They do not need to live in Oregon. They do not need a prescription, a diagnosis, or a referral from you.

Three answers on the Client Information Form can render a client ineligible:

These are regulatory eligibility criteria, not a clinical risk assessment. The form is a floor, not a substitute for judgment. Facilitators may also decline to serve any client for any reason, including when a client’s needs exceed the facilitator’s expertise. Under the Client Bill of Rights, clients choose their facilitator.

What You Should Know Before You Refer

You are not the gatekeeper. The program deliberately sits outside the medical referral system. Your role is to support informed decision-making, not to authorize access.

You will not receive records. No client record may be stored anywhere other than the service center where the client participates. A facilitator may not disclose identifying information, or anything a client said in the course of services, to anyone without the client’s written consent — including you. If you want a channel back, the client has to open it.

Medications get documented, not evaluated. Clients complete a Client Medication and Medical/Assistive Device Form during preparation. Facilitators work within their scope of practice. They are not assessing your client’s medication regimen. If there is a question there, it is yours.

Support persons are available. Clients with toileting, mobility, medication, assistive device, or interpretation needs may have an interpreter or client support person present during administration. Clients may also request an observer.

Cost is unregulated. OPS has no authority over pricing. Facilitators and service centers set their own. Some offer sliding scale.

Clients can file complaints. OPS investigates. Final orders are published on the OPS Data Dashboard.

What Clients Actually Consume

Products are cultivated or produced by a licensed manufacturer, tested by a laboratory accredited under the Oregon Environmental Laboratory Accreditation Program, and tracked from production to sale. Production by chemical synthesis is prohibited. Adulterants are prohibited.

Testing covers potency and species identification. Potency is reported in milligrams of psilocybin analyte. Every product is packaged and labeled before it reaches a service center.

Clients may purchase an optional secondary dose ahead of the session in case they want to increase their total dose during administration. Unused secondary doses are returned or destroyed and refunded. Psilocybin cannot be sold to an intoxicated client, so the decision is made before anything is consumed.

The Psilocybin Product Potency Information document is written for clients and facilitators to review together during preparation. It is the clearest public explanation of what the numbers on a label mean.

Facilitator Scope of Practice

Facilitation is non-directive. The facilitator is present to support the client without interpreting, diagnosing, or steering the outcome. During administration, facilitators may not provide health care or behavioral health services — regardless of what else they are licensed to do.

This is the line that matters most for clinicians. Administration is not therapy, and a therapist in the room is not acting as a therapist.

Facilitators are trained to recognize safety risks, respond when an experience becomes difficult, and refer out. They must disclose conflicts of interest and put client interests above their own. They may not handle, sell, administer, or consume psilocybin while providing services. Supportive touch requires prior written consent and is limited by rule.

Music and other sensory elements require prior consent, which the client may withdraw at any time.

If You Want to Facilitate: HB 2387 and Dual Licensure

House Bill 2387 passed in 2025. Effective January 1, 2026, it changed two things for clinicians.

It protects your license. HB 2387 prohibits seven Oregon boards from disciplining their licensees for lawfully providing psilocybin services as a licensed facilitator:

It lets you practice both licenses at once — in prep and integration only. A facilitator licensed under ORS 475A who also holds one of those licenses may conduct preparation and integration sessions while providing health care or behavioral health services under their other license. Administration remains non-directive. No clinical practice during administration, full stop.

You must notify OHA. The protections and privileges apply after you notify the Authority in the form and manner it prescribes. Contact your board directly with questions about how this interacts with your existing license.

Getting licensed. You must complete an OHA-approved facilitator training program including core training and a practicum, pass a comprehensive skills exam and a regulations exam, pass an Oregon Background Check Unit check, and submit a social equity plan. Training programs may award accelerated credit for prior credentialing, education, or experience in established plant or fungi-based healing traditions. Once licensed: four hours of continuing education every license year, and a social equity plan evaluation report at renewal.

Find a Facilitator or Service Center

Shroom Maps pulls licensing data from OPS and makes it searchable.

Browse Facilitators

Filter by city, specialty, and practice characteristics. Completed profiles include background, fees, session formats, and affiliated service centers.

Browse Service Centers

Search licensed premises by location. Listings include address, contact information, and the center’s own site.

Clients can also start from the OPS Licensee Directory, which lists licensees who consented to publication, or verify a license using the state’s Search for License or Permit Status tool.

Most centers do not take walk-ins. Wait times run from 24 hours to several weeks.

Official Resources

Shroom Maps is an independent directory and is not affiliated with Oregon Psilocybin Services or the Oregon Health Authority. Licensing data is sourced from OPS. For official program information, visit oregon.gov/psilocybin. Psilocybin remains a Schedule I substance under the federal Controlled Substances Act.